J. Zhong

Lequn Li, J. Zhong, X. You, 2012, European journal of surgical oncology : the journal of the European Society of Surgical Oncology and the British Association of Surgical Oncology.

Expression of P62 in hepatocellular carcinoma involving hepatitis B virus infection and aflatoxin B1 exposure

Lequn Li, J. Zhong, X. You, 2017, Cancer medicine.

Current knowledge about the outbreak of acute severe hepatitis of unknown origin among children

J. Zhong, Guan-Yu Wang, Li-Xin Pan, 2022, Journal of clinical and translational research.

Circulating Tumor Cells Undergoing EMT Provide a Metric for Diagnosis and Prognosis of Patients with Hepatocellular Carcinoma.

Lequn Li, J. Zhong, W. Gong, 2018, Cancer research.

18F-FDG PET with or without CT in the diagnosis of extrahepatic metastases or local residual/recurrent hepatocellular carcinoma

J. Zhong, Changyuan Wei, Zhi-Hui Liu, 2018, Medicine.

Letter: role of tenofovir to prevent mother‐to‐child transmission of hepatitis B virus

J. Zhong, B. Ahir, G-B Wu, 2017, Alimentary pharmacology & therapeutics.

Perioperative entecavir for patients with HBV-related hepatocellular carcinoma and low levels of viral DNA: analysis using propensity score matching.

M. Zheng, Tian Yang, Lequn Li, 2017, Oncotarget.

Antiviral therapy for hepatitis B virus-related hepatocellular carcinoma after radical hepatectomy

Lequn Li, J. Zhong, X. You, 2013, Cancer biology & medicine.

Effects of antiviral therapy on post-hepatectomy HBV reactivation and liver function in HBV DNA-negative patients with HBV-related hepatocellular carcinoma

Lequn Li, J. Zhong, W. Gong, 2017, Oncotarget.

Transarterial embolization with or without chemotherapy for advanced hepatocellular carcinoma: a systematic review

Lequn Li, J. Zhong, T. Bai, 2014, Tumor Biology.

Association between polymorphisms in MicroRNA target sites of RAD51D genes and risk of hepatocellular carcinoma

Xianguo Zhou, Zixiong Zhou, J. Zhong, 2019, Cancer medicine.

Novel combination of celecoxib and metformin improves the antitumor effect by inhibiting the growth of Hepatocellular Carcinoma

Jie Zhang, J. Zhong, Junhao Hu, 2020, Journal of Cancer.

Prognostic value of PD –L1 expression in patients with primary solid tumors

Lequn Li, J. Zhong, X. You, 2017, Oncotarget.

High expression of AKR1B10 predicts low risk of early tumor recurrence in patients with hepatitis B virus-related hepatocellular carcinoma

Lequn Li, J. Zhong, X. You, 2017, Scientific Reports.

Advances in the Detection of Pancreatic Cancer Through Liquid Biopsy

Z. Mo, J. Zhong, B. Ahir, 2021, Frontiers in Oncology.

Preoperative Ratio of Neutrophils to Lymphocytes Predicts Postresection Survival in Selected Patients With Early or Intermediate Stage Hepatocellular Carcinoma

Lequn Li, J. Zhong, X. You, 2016, Medicine.

Immune Checkpoint Inhibitors in Hepatocellular Carcinoma: Current Progresses and Challenges

Meng Jiang, Haotian Liu, Lequn Li, 2021, Frontiers in Oncology.

Evaluation of liver regeneration and post-hepatectomy liver failure after hemihepatectomy in patients with hepatocellular carcinoma

Zhi-Yuan Zhang, Lequn Li, J. Zhong, 2019, Bioscience reports.

Potential Role and Clinical Value of PPP2CA in Hepatocellular Carcinoma

J. Zhong, Xiyi Li, Shen Tang, 2021, Journal of clinical and translational hepatology.

Lenvatinib with or without immune checkpoint inhibitors for patients with unresectable hepatocellular carcinoma in real-world clinical practice

Wei Wei, Lequn Li, J. Zhong, 2021, Cancer Immunology, Immunotherapy.

Improving patient selection for selective internal radiation therapy of intra‐hepatic cholangiocarcinoma: A meta‐regression study

R. Golfieri, A. Cucchetti, C. Mosconi, 2017, Liver international : official journal of the International Association for the Study of the Liver.

Comparison of Survival of Patients with BCLC Stage A Hepatocellular Carcinoma After Hepatic Resection or Transarterial Chemoembolization: A Propensity Score-Based Analysis

Lequn Li, J. Zhong, Zhe Guo, 2014, Annals of Surgical Oncology.

Albumin–bilirubin versus Child–Pugh score as a predictor of outcome after liver resection for hepatocellular carcinoma

Lequn Li, J. Zhong, L. Ma, 2016, The British journal of surgery.

Non-classic radiation-induced liver disease after intensity-modulated radiotherapy for Child–Pugh grade B patients with locally advanced hepatocellular carcinoma

J. Zhong, B. Xiang, Jian-Xu Li, 2023, Radiation Oncology.

Epidermal Growth Factor Gene Polymorphism and Risk of Hepatocellular Carcinoma: A Meta-Analysis

Lequn Li, J. Zhong, W. Gong, 2012, PloS one.

Postoperative hepatitis B virus reactivation and surgery‐induced immunosuppression in patients with hepatitis B‐related hepatocellular carcinoma

Lequn Li, J. Zhong, Jie Chen, 2015, Journal of surgical oncology.

Microvesicles packaging IL‐1&bgr; and TNF‐&agr; enhance lung inflammatory response to mechanical ventilation in part by induction of cofilin signaling

J. Zhong, Lingyu Zhu, Weikang Zhang, 2018, International immunopharmacology.

Single Nucleotide Polymorphism 8q24 rs13281615 and Risk of Breast Cancer: Meta-Analysis of More than 100,000 Cases

Lequn Li, J. Zhong, W. Gong, 2013, PloS one.

Adjuvant imatinib for gastrointestinal stromal tumors: the current situation and problems

Lequn Li, J. Zhong, Liang Ma, 2011, Scandinavian journal of gastroenterology.

Primary intraosseous myxoid chondrosarcoma arising in the right radius

J. Zhong, Ying Huang, Changhong Wei, 2018 .

Development of a preoperative prognostic scoring system to predict benefits of hepatic resection in advanced hepatocellular carcinoma patients

J Zhang, Lequn Li, J. Zhong, 2021, Bioscience reports.

Systematic Review of Single Large and/or Multinodular Hepatocellular Carcinoma: Surgical Resection Improves Survival.

Lequn Li, J. Zhong, Lin Wang, 2015, Asian Pacific journal of cancer prevention : APJCP.

Repeat hepatic resection versus radiofrequency ablation for recurrent hepatocellular carcinoma: a retrospective multicentre study.

B. Xing, A. Cucchetti, M. Cescon, 2021, The British journal of surgery.

Hepatic Resection Associated With Good Survival for Selected Patients With Intermediate and Advanced-Stage Hepatocellular Carcinoma

Lequn Li, J. Zhong, W. Gong, 2014, Annals of surgery.

Clinical Features of Recurrence After Hepatic Resection for Early-Stage Hepatocellular Carcinoma and Long-Term Survival Outcomes of Patients with Recurrence: A Multi-institutional Analysis

T. Pawlik, W. Lau, Tian Yang, 2022, Annals of Surgical Oncology.

Controversies and evidence of hepatic resection for hepatocellular carcinoma☆

G. Torzilli, Han Zhang, Jun Han, 2016, BBA clinical.

Treatment of hepatocellular carcinoma with portal vein tumor thrombus: advances and challenges

J. Zhong, Bao-hong Yuan, Long Chen, 2017, Oncotarget.

Development of pre and post-operative models to predict early recurrence of hepatocellular carcinoma after surgical resection.

M. García-Fiñana, V. Mazzaferro, M. Kudo, 2018, Journal of hepatology.

Try113His and His139Arg polymorphisms in the microsomal epoxide hydrolase gene are not associated with risk of breast cancer

Lequn Li, J. Zhong, W. Gong, 2014, Tumor Biology.

Comparison of postoperative immune function in patients with thoracic esophageal cancer after video-assisted thoracoscopic surgery or conventional open esophagectomy.

J. Zhong, N. Mao, Chuan-tian Zuo, 2016, International journal of surgery.

Identification of CD14 as a potential biomarker of hepatocellular carcinoma using iTRAQ quantitative proteomics

R. Jing, J. Zhong, Tian-ren Huang, 2017, Oncotarget.

An Analysis of EGFR Mutations among 1506 Cases of Non-Small Cell Lung Cancer Patients in Guangxi, China

Jilin Li, J. Zhong, Litu Zhang, 2016, PloS one.

Optimizing stage of single large hepatocellular carcinoma

A. Cucchetti, Tian Yang, Lequn Li, 2017, Medicine.

Efficacy of hepatic resection for huge (≥ 10 cm) hepatocellular carcinoma: good prognosis associated with the uninodular subtype.

Lequn Li, J. Zhong, Jie Chen, 2015, International journal of clinical and experimental medicine.

Systematic review of risk factors of hepatocellular carcinoma after hepatitis B surface antigen seroclearance

J. Zhong, Z. Peng, B. Xiang, 2018, Journal of viral hepatitis.

Prognosis after hepatic resection of patients with hepatocellular carcinoma related to non-alcoholic fatty liver disease: meta-analysis

M. Zheng, Chao-Long Chen, Y. Koh, 2023, BJS open.

Impact of concurrent splenectomy and esophagogastric devascularization on surgical outcomes of partial hepatectomy for hepatocellular carcinoma in patients with clinically significant portal hypertension: A multicenter propensity score matching analysis.

T. Pawlik, W. Lau, Han Wu, 2021, European journal of surgical oncology : the journal of the European Society of Surgical Oncology and the British Association of Surgical Oncology.

Systematic review comparing the safety and efficacy of conventional and drug‐eluting bead transarterial chemoembolization for inoperable hepatocellular carcinoma

Lequn Li, J. Zhong, W. Gong, 2015, Hepatology research : the official journal of the Japan Society of Hepatology.

Comparison of three‐dimensional conformal radiotherapy and hepatic resection in hepatocellular carcinoma with portal vein tumor thrombus

Xiao-dong Zhu, F. Su, Long Chen, 2018, Cancer medicine.

Multi-b value diffusion-weighted magnetic resonance imaging and intravoxel incoherent motion modeling

X. Tan, H. Cen, Lequn Li, 2019, Medicine.

Functional Magnetic Resonance Imaging in the Diagnosis of Locally Recurrent Prostate Cancer: Are All Pulse Sequences Helpful?

J. Zhong, Changyuan Wei, Jun-Bao Wei, 2018, Korean journal of radiology.

Comparison of Long-Term Survival of Patients with Solitary Large Hepatocellular Carcinoma of BCLC Stage A after Liver Resection or Transarterial Chemoembolization: A Propensity Score Analysis

Lequn Li, J. Zhong, Liang Ma, 2014, PloS one.

Comparison of Long-Term Survival of Patients with BCLC Stage B Hepatocellular Carcinoma after Liver Resection or Transarterial Chemoembolization

Lequn Li, J. Zhong, W. Gong, 2013, PloS one.

Transarterial chemoembolization versus best supportive care for patients with hepatocellular carcinoma with portal vein tumor thrombus：a multicenter study.

W. Lau, Lequn Li, J. Zhong, 2019, European journal of surgical oncology : the journal of the European Society of Surgical Oncology and the British Association of Surgical Oncology.

Treatments of Hepatocellular Carcinoma with Portal Vein Tumor Thrombus: Current Status and Controversy

J. Zhong, Liang Ma, Jian-Li Huang, 2021, Journal of clinical and translational hepatology.

New Evidence and Perspectives on the Management of Hepatocellular Carcinoma with Portal Vein Tumor Thrombus

J. Lang, Lequn Li, J. Zhong, 2017, Journal of clinical and translational hepatology.

Hepatic resection for elderly patients with hepatocellular carcinoma: a systematic review of more than 17,000 patients

M. Zheng, G. Torzilli, Tian Yang, 2018, Expert review of gastroenterology & hepatology.

Correlation between serum prealbumin and prognosis of patients with hepatocellular carcinoma after hepatectomy

Lequn Li, J. Zhong, B. Xiang, 2019, Journal of surgical oncology.

Antiviral therapy for hepatitis B virus-related hepatocellular carcinoma after surgery: A comment for moving forward.

Tian Yang, Lequn Li, J. Zhong, 2016, World journal of hepatology.

Adoptive immunotherapy for postoperative hepatocellular carcinoma: a systematic review

J. Zhong, L. Ma, X. You, 2012, International journal of clinical practice.

miR-17-5p slows progression of hepatocellular carcinoma by downregulating TGFβR2

Meng Jiang, Haotian Liu, J. Zhong, 2023, Clinical and Translational Oncology.

S100P as a novel biomarker of microvascular invasion and portal vein tumor thrombus in hepatocellular carcinoma

Lequn Li, J. Zhong, W. Gong, 2021, Hepatology International.

Surgical resection versus transarterial chemoembolization for BCLC intermediate stage hepatocellular carcinoma: a systematic review and meta-analysis.

W. Lau, Han Zhang, Tian Yang, 2017, HPB : the official journal of the International Hepato Pancreato Biliary Association.

We're Still in an Update Process of the BCLC System.

Tian Yang, Lequn Li, J. Zhong, 2018, Annals of surgery.

Therapeutic role of systematic lymphadenectomy in early-stage endometrial cancer: A systematic review.

J. Zhong, Xiao-xia Hu, Yong Lin, 2016, Oncology letters.

Development and Validation of a Nomogram to Preoperatively Estimate Post-hepatectomy Liver Dysfunction Risk and Long-term Survival in Patients With Hepatocellular Carcinoma

B. Xing, Lequn Li, J. Zhong, 2020, Annals of surgery.

Overexpression of Epcam and CD133 Correlates with Poor Prognosis in Dual-phenotype Hepatocellular Carcinoma

J Zhang, N. Ma, Lequn Li, 2020, Journal of Cancer.

Comparison of hepatectomy with or without hepatic inflow occlusion in patients with hepatocellular carcinoma: a single-center experience.

Lequn Li, J. Zhong, Jiye Zhu, 2017, Minerva medica.

Association of the miR-196a2 C>T and miR-499 A>G polymorphisms with hepatitis B virus-related hepatocellular carcinoma risk: an updated meta-analysis

Lequn Li, J. Zhong, W. Gong, 2016, OncoTargets and therapy.

Association of two common microRNA gene polymorphisms with risk of hepatocellular carcinoma : a meta-analysis

Lequn Li, J. Zhong, W. Gong, 2016 .

Case report: Conversion therapy to permit resection of initially unresectable hepatocellular carcinoma

Lequn Li, J. Zhong, X. You, 2022, Frontiers in Oncology.

Tumor stage and primary treatment of hepatocellular carcinoma at a large tertiary hospital in China: A real-world study

Lequn Li, J. Zhong, W. Gong, 2017, Oncotarget.

Timely meta-analysis on the efficacy of adoptive immunotherapy for hepatocellular carcinoma patients after curative therapy

A. Cucchetti, Lequn Li, J. Zhong, 2017, PloS one.

Comparison of survival rates as predicted by total tumor volume or tumor burden score in patients with hepatocellular carcinoma concurrent with fatty liver disease and hepatitis B virus

Lequn Li, J. Zhong, B. Xiang, 2023, Expert review of gastroenterology & hepatology.

Hepatic Resection as a Safe and Effective Treatment for Hepatocellular Carcinoma Involving a Single Large Tumor, Multiple Tumors, or Macrovascular Invasion

Lequn Li, J. Zhong, Lin Wang, 2015, Medicine.

Liver resection for patients with hepatocellular carcinoma and macrovascular invasion, multiple tumours, or portal hypertension

Lequn Li, J. Zhong, Yan-Yan Wang, 2014, Gut.

Propensity score-based comparison of hepatic resection and transarterial chemoembolization for patients with advanced hepatocellular carcinoma

Lequn Li, J. Zhong, W. Gong, 2016, Tumor Biology.

Dose–Response Between Serum Prealbumin and All-Cause Mortality After Hepatectomy in Patients With Hepatocellular Carcinoma

Haotian Liu, Lequn Li, J. Zhong, 2021, Frontiers in Oncology.

Adjuvant transarterial chemoembolization for patients with hepatocellular carcinoma involving microvascular invasion.

Bin Chen, Lequn Li, J. Zhong, 2019, American journal of surgery.

Hepatic resection as a safe and effective treatment for hepatocellular carcinoma involving a single large tumor, multiple tumors, or macrovascular invasion: erratum.

Lequn Li, J. Zhong, Lin Wang, 2015, Medicine.

Postoperative hepatitis B virus reactivation in hepatitis B virus-related hepatocellular carcinoma patients with hepatitis B virus DNA levels <500 copies/mL

Lequn Li, J. Zhong, Xiao-bo Wang, 2016, OncoTargets and therapy.

Hepatic Resection Is Safe and Effective for Patients with Hepatocellular Carcinoma and Portal Hypertension

Zhi-Yuan Zhang, Lequn Li, J. Zhong, 2014, PloS one.

Serum Prealbumin is Negatively Associated with Survival in Hepatocellular Carcinoma Patients after Hepatic Resection

Lequn Li, J. Zhong, K. Chen, 2019, Journal of Cancer.

Systematic review of treatment strategy for recurrent hepatocellular carcinoma

Lequn Li, J. Zhong, B. Xiang, 2019, Medicine.

The role of SSM and LSPS in predicting posthepatectomy liver failure should be further evaluated

Lequn Li, J. Zhong, Yan-Yan Wang, 2019, Journal of surgical oncology.

Postoperative Use of the Chemopreventive Vitamin K2 Analog in Patients with Hepatocellular Carcinoma

Lequn Li, J. Zhong, X. Mo, 2013, PloS one.

Transarterial embolization for hepatocellular adenomas: Case report and literature review

Lequn Li, J. Zhong, K. Chen, 2018 .

Retracted: Systematic review: benefits and harms of transarterial embolisation for treating hepatocellular adenoma

A. Cucchetti, Lequn Li, J. Zhong, 2017, Alimentary pharmacology & therapeutics.

Outcomes of anatomical versus non-anatomical resection for hepatocellular carcinoma according to circulating tumour-cell status

Lequn Li, J. Zhong, W. Gong, 2019, Annals of medicine.

Association between COX-2 gene polymorphisms and risk of hepatocellular carcinoma development: a meta-analysis

Lequn Li, J. Zhong, T. Peng, 2015, BMJ Open.

Tenofovir may be superior to entecavir for preventing hepatocellular carcinoma and mortality in individuals chronically infected with HBV: a meta-analysis

J. Zhong, B. Xiang, Yuxian Teng, 2019, Gut.

A modified staging of early and intermediate hepatocellular carcinoma based on single tumour >7 cm and multiple tumours beyond up‐to‐seven criteria

Haifeng Xu, B. Xing, Gang Xu, 2018, Alimentary pharmacology & therapeutics.

Hepatic resection is superior to transarterial chemoembolization for treating intermediate‐stage hepatocellular carcinoma

Lequn Li, J. Zhong, X. You, 2017, Liver international : official journal of the International Association for the Study of the Liver.

Subclassification of patients with solitary hepatocellular carcinoma based on post-hepatectomy survival: a large retrospective study

L. Pan, Lequn Li, J. Zhong, 2016, Tumor Biology.

Comment on staging hepatocellular carcinoma involving a single large tumor

Lequn Li, J. Zhong, L. Deng, 2016 .

Comment on a meta-analysis comparing hepatic resection or transarterial chemoembolization as initial treatment for hepatocellular carcinoma

Lequn Li, J. Zhong, B. Xiang, 2015, Drug design, development and therapy.

Historical Comparison of Overall Survival after Hepatic Resection for Patients With Large and/or Multinodular Hepatocellular Carcinoma

Lequn Li, J. Zhong, X. You, 2015, Medicine.

Selection of patients with solitary hepatocellular carcinoma for hepatic resection: reassessment of a 5-cm tumor size cut-off

M. Zheng, A. Cucchetti, Y. Lv, 2017 .

A premature proposal for new liver cancer seromarkers

J. Zhong, W. Gong, Liu-Cheng Wu, 2016, Tumor Biology.

Intermediate-stage HCC—upfront resection can be feasible

Lequn Li, J. Zhong, Liang Ma, 2015, Nature Reviews Clinical Oncology.

Paraneoplastic Syndrome May be a Favorable Prognostic Factor in Patients with Hepatocellular Carcinoma Following Hepatectomy

Lequn Li, J. Zhong, B. Xiang, 2019 .

Blood transfusion and postoperative complications: a cautionary comment.

Lequn Li, J. Zhong, B. Xiang, 2016, Translational gastroenterology and hepatology.

Letter: older age and male gender increase the risk of hepatocellular carcinoma after hepatitis B surface antigen (HBsAg) seroclearance

J. Zhong, W. Gong, B. Xiang, 2017, Alimentary pharmacology & therapeutics.

Letter: clinical outcomes of HBsAg loss in chronic HBV infection

J. Zhong, L.‐Q. Li, C. Zhao, 2016, Alimentary pharmacology & therapeutics.

Hepatic resection associated with good survival for selected patients with multinodular hepatocellular carcinoma

J. Zhong, Hang Li, Fei-Xiang Wu, 2014, Tumor Biology.

Outcomes of Liver Resection for Metabolic Dysfunction-Associated Fatty Liver Disease or Chronic Hepatitis B-Related HCC

Lequn Li, J. Zhong, Kang Chen, 2022, Frontiers in Oncology.

Adjuvant immune checkpoint inhibitors associated with higher recurrence-free survival in postoperative hepatocellular carcinoma (PREVENT): a prospective, multicentric cohort study

J. Zhong, Shan Huang, Kang Chen, 2023, Journal of Gastroenterology.

Methylenetetrahydrofolate Reductase Gene Polymorphism and Risk of Type 2 Diabetes Mellitus

Lequn Li, J. Zhong, Na Yang, 2013, PloS one.

Analysis of Clinicopathological Characteristics and Prognosis of Young Patients with Hepatocellular Carcinoma after Hepatectomy

Haotian Liu, B. Xiang, Lequn Li, 2020, Journal of clinical and translational hepatology.

Comment on tumor size as a prognostic factor for solitary HCC after resection

Lequn Li, J. Zhong, Han-Yue Mo, 2016, Journal of surgical oncology.

MiR-141-3p suppresses gastric cancer induced transition of normal fibroblast and BMSC to cancer-associated fibroblasts via targeting STAT4.

Yongchun Zhou, J. Zhong, Fu-sheng Gong, 2019, Experimental and molecular pathology.

Contrast-Enhanced Ultrasound to Monitor Early Recurrence of Primary Hepatocellular Carcinoma after Curative Treatment

Lequn Li, J. Zhong, Jun-jie Liu, 2018, BioMed research international.

Postoperative antiviral therapy with nucleos(t)ide analogs for patients with hepatitis B virus-related hepatocellular carcinoma.

Lequn Li, J. Zhong, Jinghang Jiang, 2016, Clinics And Research in Hepatology and Gastroenterology.

[Comparison liver resection with transarterial chemoembolization for Barcelona Clinic Liver Cancer stage B hepatocellular carcinoma patients on long-term survival after SPSS propensity score matching].

Lequn Li, J. Zhong, Zhe Guo, 2014, Zhonghua yi xue za zhi.

Distribution of tumor stage and initial treatment modality in patients with primary hepatocellular carcinoma

J. Zhong, X. You, B. Xiang, 2017, Clinical and Translational Oncology.

Are another 5 years of adjuvant aromatase inhibitor therapy needed?

De-Quan Li, J. Zhong, Changyuan Wei, 2016, Breast cancer.

Adefovir dipivoxil is less expensive than lamivudine and associated with similar prognosis in patients with hepatitis B virus-related hepatocellular carcinoma after radical resection.

Lequn Li, J. Zhong, W. Gong, 2016 .

Impact of Diabetes Mellitus on the Prognosis of Patients with Hepatocellular Carcinoma after Curative Hepatectomy

Lequn Li, J. Zhong, Shan Huang, 2014, PloS one.

Oncotargets and Therapy Dovepress

Haiquan Chen, Q. Lu, Yuan Li, 2022 .

Does the elevation of serum carbohydrate antigen 19-9 level predict poor overall survival in patients with hepatocellular carcinoma?

Lequn Li, J. Zhong, Yan-Yan Wang, 2015, Tumor Biology.

Comparative efficacy of vasoconstrictor therapies for type 1 hepatorenal syndrome: a network meta-analysis

M. Braddock, M. Zheng, Dan-Qin Sun, 2017, Expert review of gastroenterology & hepatology.

Hepatectomy combined with apatinib and camrelizumab for CNLC stage IIIb hepatocellular carcinoma: a phase II trial protocol

J. Zhong, W. Gong, B. Xiang, 2023, BMJ Open.

Transarterial Embolization With or Without Chemotherapy: What Should Be the Indication for Patients With Hepatocellular Carcinoma?

J. Zhong, Chang Zhao, Jun-Tao Tan, 2017, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

Comparison of postoperative immune function in patients with thoracic esophageal cancer after video-assisted thoracoscopic surgery or conventional open esophagectomy.

J. Zhong, N. Mao, Chuan-tian Zuo, 2016, International journal of surgery.

Letter: sex disparity in prognosis of patients with hepatocellular carcinoma after resection

Haotian Liu, J. Zhong, W. Gong, 2020, Alimentary pharmacology & therapeutics.